ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, supplying promising progress across numerous healthcare and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA gives a safer, much more responsible alternate for therapeutic use